Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
10 Mar 2017
|
| In: |
Stroke
Year: 2017, Jahrgang: 48, Heft: 4, Pages: e114 |
| ISSN: | 1524-4628 |
| DOI: | 10.1161/STROKEAHA.117.016603 |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1161/STROKEAHA.117.016603
|
| Verfasserangaben: | Daniel Hänggi and R. Loch Macdonald |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581552386 | ||
| 003 | DE-627 | ||
| 005 | 20220815023906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181004s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/STROKEAHA.117.016603 |2 doi | |
| 035 | |a (DE-627)1581552386 | ||
| 035 | |a (DE-576)511552386 | ||
| 035 | |a (DE-599)BSZ511552386 | ||
| 035 | |a (OCoLC)1341019336 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hänggi, Daniel |d 1970- |e VerfasserIn |0 (DE-588)1070887269 |0 (DE-627)824720172 |0 (DE-576)432795715 |4 aut | |
| 245 | 1 | 0 | |a Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |c Daniel Hänggi and R. Loch Macdonald |
| 264 | 1 | |c 10 Mar 2017 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.10.2018 | ||
| 700 | 1 | |a Macdonald, Robert Loch |e VerfasserIn |0 (DE-588)129647748 |0 (DE-627)476245176 |0 (DE-576)184938244 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Stroke |d New York, NY : Association, 1970 |g 48(2017), 4, Seite e114 |h Online-Ressource |w (DE-627)266879985 |w (DE-600)1467823-8 |w (DE-576)075145731 |x 1524-4628 |7 nnas |a Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |
| 773 | 1 | 8 | |g volume:48 |g year:2017 |g number:4 |g pages:e114 |g extent:1 |a Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/STROKEAHA.117.016603 |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181004 | ||
| 993 | |a Editorial | ||
| 994 | |a 2017 | ||
| 998 | |g 1070887269 |a Hänggi, Daniel |m 1070887269:Hänggi, Daniel |d 60000 |d 62600 |e 60000PH1070887269 |e 62600PH1070887269 |k 0/60000/ |k 1/60000/62600/ |p 1 |x j | ||
| 999 | |a KXP-PPN1581552386 |e 3027691716 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Daniel Hänggi and R. Loch Macdonald"]},"relHost":[{"title":[{"title":"Stroke","title_sort":"Stroke","subtitle":"journal of the American Heart Association"}],"pubHistory":["1.1970 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1970","publisher":"Association ; Lippincott Williams & Wilkins","dateIssuedDisp":"1970-","publisherPlace":"New York, NY ; Philadelphia, Pa."}],"note":["Gesehen am 29.06.04"],"recId":"266879985","id":{"eki":["266879985"],"zdb":["1467823-8"],"issn":["1524-4628"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])Stroke","corporate":[{"role":"isb","display":"American Heart Association"}],"part":{"extent":"1","pages":"e114","volume":"48","text":"48(2017), 4, Seite e114","issue":"4","year":"2017"},"language":["eng"]}],"recId":"1581552386","id":{"eki":["1581552386"],"doi":["10.1161/STROKEAHA.117.016603"]},"language":["eng"],"physDesc":[{"extent":"1 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"10 Mar 2017"}],"person":[{"role":"aut","display":"Hänggi, Daniel","given":"Daniel","family":"Hänggi"},{"role":"aut","given":"Robert Loch","family":"Macdonald","display":"Macdonald, Robert Loch"}],"title":[{"title":"Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])","title_sort":"Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])"}],"note":["Gesehen am 04.10.2018"]} | ||
| SRT | |a HAENGGIDANRESPONSEBY1020 | ||